Showing results (461-470 of 487) with videos related to

Sort By:
Pageof 49
Journal of Translational Medicine|February 14, 2016
First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementiaFrank C Barone, Deborah Gustafson, Howard A Crystal, et al.
The Journal of Clinical Investigation|September 7, 2006
Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vesselsJohannes-Peter Stasch, Peter M Schmidt, Pavel I Nedvetsky, et al.
Nature Communications|October 8, 2015
Cardiovascular and pharmacological implications of haem-deficient NO-unresponsive soluble guanylate cyclase knock-in miceRobrecht Thoonen, Anje Cauwels, Kelly Decaluwe, et al.
Blood|February 5, 2011
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantationMauro Di Ianni, Franca Falzetti, Alessandra Carotti, et al.
Respiratory Research|October 1, 2022
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGCEva M Becker-Pelster, Michael G Hahn, Martina Delbeck, et al.
Stroke|January 7, 2012
The argatroban and tissue-type plasminogen activator stroke study: final results of a pilot safety studyAndrew D Barreto, Andrei V Alexandrov, Pat Lyden, et al.
Circulation. Cardiovascular Genetics|November 6, 2014
α1-A680T variant in GUCY1A3 as a candidate conferring protection from pulmonary hypertension among Kyrgyz highlandersMartin R Wilkins, Almaz A Aldashev, John Wharton, et al.
Heart Failure Reviews|May 25, 2012
Soluble guanylate cyclase: a potential therapeutic target for heart failureMihai Gheorghiade, Catherine N Marti, Hani N Sabbah, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 8, 2020
Beneficial Effects of Soluble Guanylyl Cyclase Stimulation and Activation in Sickle Cell Disease Are Amplified by Hydroxyurea: In Vitro and In Vivo StudiesW A Ferreira, H Chweih, C Lanaro, et al.
Pageof 49